265 related articles for article (PubMed ID: 29050119)
1. [Feasibility of domestic (18)F-DOPA PET/CT scanning in the differential diagnosis of pancreatic lesions in children with hyperinsulinemic hypoglycemia].
Zhang MY; Ge JJ; Pei Z; Dong KR; Chen L; Wang X; Zhang ZW; Li XJ; Xi L; Cheng RQ; Lu GP; Guan YH; Luo FH
Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):785-789. PubMed ID: 29050119
[No Abstract] [Full Text] [Related]
2. [Clinical features of 123 patients with hyperinsulinemic hypoglycemia auxiliarily diagnosed by
Zhang MY; Ni JW; Ge JJ; Guan YH; Pei Z; Sun CJ; Wu J; Xu ZR; Yang L; Luo FH; Cheng RQ
Zhonghua Er Ke Za Zhi; 2021 Oct; 59(10):853-858. PubMed ID: 34587682
[No Abstract] [Full Text] [Related]
3. 18F-DOPA PET and enhanced CT imaging for congenital hyperinsulinism: initial UK experience from a technologist's perspective.
Meintjes M; Endozo R; Dickson J; Erlandsson K; Hussain K; Townsend C; Menezes L; Bomanji J
Nucl Med Commun; 2013 Jun; 34(6):601-8. PubMed ID: 23571817
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy.
Zani A; Nah SA; Ron O; Totonelli G; Ismail D; Smith VV; Ashworth M; Blankenstein O; Mohnike W; De Coppi P; Eaton S; Hussain K; Pierro A
J Pediatr Surg; 2011 Jan; 46(1):204-8. PubMed ID: 21238668
[TBL] [Abstract][Full Text] [Related]
5. The role of
Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism.
Barthlen W; Blankenstein O; Mau H; Koch M; Höhne C; Mohnike W; Eberhard T; Fuechtner F; Lorenz-Depiereux B; Mohnike K
J Clin Endocrinol Metab; 2008 Mar; 93(3):869-75. PubMed ID: 18073294
[TBL] [Abstract][Full Text] [Related]
7. 18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation.
Christiansen CD; Petersen H; Nielsen AL; Detlefsen S; Brusgaard K; Rasmussen L; Melikyan M; Ekström K; Globa E; Rasmussen AH; Hovendal C; Christesen HT
Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):250-261. PubMed ID: 29116340
[TBL] [Abstract][Full Text] [Related]
8. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
9. Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion.
de Lonlay P; Simon-Carre A; Ribeiro MJ; Boddaert N; Giurgea I; Laborde K; Bellanné-Chantelot C; Verkarre V; Polak M; Rahier J; Syrota A; Seidenwurm D; Nihoul-Fékété C; Robert JJ; Brunelle F; Jaubert F
J Clin Endocrinol Metab; 2006 Mar; 91(3):933-40. PubMed ID: 16403819
[TBL] [Abstract][Full Text] [Related]
10. Fluorine-18-L-dihydroxyphenylalanine (18F-DOPA) positron emission tomography as a tool to localize an insulinoma or beta-cell hyperplasia in adult patients.
Kauhanen S; Seppänen M; Minn H; Gullichsen R; Salonen A; Alanen K; Parkkola R; Solin O; Bergman J; Sane T; Salmi J; Välimäki M; Nuutila P
J Clin Endocrinol Metab; 2007 Apr; 92(4):1237-44. PubMed ID: 17227804
[TBL] [Abstract][Full Text] [Related]
11. The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children.
Ribeiro MJ; Boddaert N; Bellanné-Chantelot C; Bourgeois S; Valayannopoulos V; Delzescaux T; Jaubert F; Nihoul-Fékété C; Brunelle F; De Lonlay P
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2120-8. PubMed ID: 17661030
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.
Otonkoski T; Näntö-Salonen K; Seppänen M; Veijola R; Huopio H; Hussain K; Tapanainen P; Eskola O; Parkkola R; Ekström K; Guiot Y; Rahier J; Laakso M; Rintala R; Nuutila P; Minn H
Diabetes; 2006 Jan; 55(1):13-8. PubMed ID: 16380471
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of giant focal forms of congenital hyperinsulinism with incorrect visualization by (18) F DOPA-PET/CT scanning.
Kühnen P; Matthae R; Arya V; Hauptmann K; Rothe K; Wächter S; Singer M; Mohnike W; Eberhard T; Raile K; Lauffer LM; Iakoubov R; Hussain K; Blankenstein O
Clin Endocrinol (Oxf); 2014 Dec; 81(6):847-54. PubMed ID: 24750227
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.
Masue M; Nishibori H; Fukuyama S; Yoshizawa A; Okamoto S; Doi R; Uemoto S; Tokumi T; Kasai T; Yorifuji T
Clin Endocrinol (Oxf); 2011 Sep; 75(3):342-6. PubMed ID: 21521340
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.
Hardy OT; Hernandez-Pampaloni M; Saffer JR; Suchi M; Ruchelli E; Zhuang H; Ganguly A; Freifelder R; Adzick NS; Alavi A; Stanley CA
J Pediatr; 2007 Feb; 150(2):140-5. PubMed ID: 17236890
[TBL] [Abstract][Full Text] [Related]
16. A compound heterozygous mutation of ABCC8 gene causing a diazoxide-unresponsive congenital hyperinsulinism with an atypical form: Not a focal lesion in the pancreas reported by ¹⁸F-DOPA-PET/CT scan.
Zhang W; Liu L; Wen Z; Cheng J; Li C; Li X; Niu H; Wang F; Sheng H; Liu H
Gene; 2015 Nov; 572(2):222-6. PubMed ID: 26162674
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
Subramaniam RM; Karantanis D; Peller PJ
J Comput Assist Tomogr; 2007; 31(5):770-2. PubMed ID: 17895790
[TBL] [Abstract][Full Text] [Related]
18. Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism.
Capito C; Khen-Dunlop N; Ribeiro MJ; Brunelle F; Aigrain Y; Crétolle C; Jaubert F; De Lonlay P; Nihoul-Fékété C
Radiology; 2009 Oct; 253(1):216-22. PubMed ID: 19709999
[TBL] [Abstract][Full Text] [Related]
19. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.
Ribeiro MJ; De Lonlay P; Delzescaux T; Boddaert N; Jaubert F; Bourgeois S; Dollé F; Nihoul-Fékété C; Syrota A; Brunelle F
J Nucl Med; 2005 Apr; 46(4):560-6. PubMed ID: 15809476
[TBL] [Abstract][Full Text] [Related]
20. Lasting 18F-DOPA PET uptake after clinical remission of the focal form of congenital hyperinsulinism.
Yorifuji T; Hosokawa Y; Fujimaru R; Kawakita R; Doi H; Matsumoto T; Nishibori H; Masue M
Horm Res Paediatr; 2011; 76(4):286-90. PubMed ID: 21912073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
